Skip to content
B
BiotechEdge
Start 14-Day Free Trial

Verona Pharma + Merck

closed

$VRNA acquired by Merck for $10.0B

Deal Summary

Deal Value
$10.0B
Price/Share
$107
Announced
Jul 8, 2025
Closed
Oct 7, 2025

Fund Positioning

6 of 20 tracked specialist biotech funds held $VRNA — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
RTW Investments3.1M$288.6MMar 2025Yes
Eventide Asset Management681K$72.7MMar 2025Yes
Perceptive Advisors524K$55.9MMar 2025Yes
Driehaus Capital338K$32.0MJun 2025Yes
Baker Bros. Advisors224K$21.2MMar 2025Yes
EcoR1 Capital200K$18.9MJun 2025Yes
← All biotech acquisitions